Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Management
View:
Post by Trogarzon on Dec 12, 2022 1:59pm

Management

This company needs a biotech entrepreneur onece again and a good CFO... we have a marketing VP seconded by a weak CFO and very weak board.  Otherwise strategic review asap.
Comment by Trogarzon on Dec 12, 2022 2:02pm
I'll take Andre De Villers and Luc Tanguay back anythime.... and late Jean-de-Granpr .... old school efficacity.
Comment by LouisW on Dec 13, 2022 1:23am
I dont know who Andre DeV Villers is..so i googled it. I realize that he was CEO of theratechnologies in 2001-2003. Surprisingly, one of TH's product, Theralux was found to be potential to fight CML in 2002. So TH1902 is not the 1st oncological product of TH. I cannot find any information of Theralux, what happen to it? Trial failed?
Comment by Stephber on Dec 13, 2022 8:21am
I think it became Kiadis Pharma bought by Sanofi in 2020-21 for €308m... https://www.sanofi.com/fr/media-room/communiques-de-presse/2020/2020-11-02-06-00-00-2118110
Comment by jfm1330 on Dec 13, 2022 8:31am
If I remember, it was transfered at some point to a spinoff company, not sure about that. It seems that it never went to phase III. https://clinicaltrials.gov/ct2/history/NCT00248365?V_7=View
Comment by jfm1330 on Dec 13, 2022 8:32am
I found it,the spinoff was a company called Celmed. https://www.tvanouvelles.ca/2003/11/17/celmed-biosciences-renforce-son-equipe
Comment by jfm1330 on Dec 13, 2022 8:34am
Anybody remembers Ecopia? Another spinoff that was supposed to be a revolution in the way to discover new drugs through genomic of bacterias and fungus.
Comment by Trogarzon on Dec 13, 2022 8:33am
It shows how good stuff can come out of Th... just bad Karma overthere... 
Comment by Stephber on Dec 13, 2022 8:37am
Other links from the old theratech subsidiary  TVA Nouvelleshttps://www.tvanouvelles.ca › celme...Celmed BioSciences intensifie ses activits de dveloppement clinique   FDAnewshttps://www.fdanews.com › printTHERATECHNOLOGIES SELLS CELMED INVESTMENT   FierceBiotechhttps://www.fiercebiotech.com › pre...Press Release: Kiadis and Celmed Merge to Create New Force in Oncology
Comment by jfm1330 on Dec 13, 2022 8:57am
Those who wanted a promotional CEO, Andre DeVillers, who was also the founder of Thera, was good at promotion, and with spinoffs like Celmed, Ecopia and Andromed with their electronic stethoscope. I found a link to this early history. Only tesamorelin ended up as a very minor success out of all that. https://www.bloomburton.com/looking-inside-the-biotech-black-box-part-5/
Comment by Trogarzon on Dec 13, 2022 9:21am
Like I said an Entrepreneur, a Visionary and Luc was CFO back Then.. a ggod CFO.... 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities